[ad_1] By Mikey Campbell Friday, October 26, 2018 at 7:40 pm Eastern Time (10:40 pm ET) Apple now has $ 7 billion late in patent royalty payments to Qualcomm after ordering contract …
Read More »
[ad_1] Breaking News Emails Receive last minute alerts and special reports. News and stories that matter, delivered the mornings of the week. SUBSCRIBE October 23, 2018 / 8:01 pm GMT By David …
Read More »[ad_1] FAYETTEVILLE, N.C. (WTVD) – From Cumberland County to the coast, the Hurricane Florence disaster continues to affect families in North Carolina. To date, state and federal officials have told ABC11 that …
Read More »
[ad_1] NEW DELHI: The US-India Business Council (USIBC) warned Tuesday that data flow restriction policies could be "barriers" to expanding services in India, affecting not only consumers, but also growth of the …
Read More »
[ad_1] Klarna, the Sweden-based start-up payment company that helps online shoppers find point-of-sale financing, has hired another strategic investor: H & M fashion retailer is taking a $ 20 million stake in …
Read More »
[ad_1] 3:04 PM ET Mark Schlabach Close ESPN Senior Writer Senior college football writer Author of seven books on college football Graduate of the University of Georgia Jeff Borzello Close ESPN Staff …
Read More »
[ad_1] A cryptocurrency whose regulatory fate remains uncertain is ready for prime time. On Monday, Ripple launched a new financial product based on XRP, the third largest cryptocurrency in the world in …
Read More »[ad_1] Senator Richard Blumenthal, D-Connecticut and other members allege in the lawsuit that the president is violating the constitutional clause on emoluments by not asking for their approval for his company to …
Read More »
[ad_1] Stripe joined the ranks of private technology groups with a valuation of $ 20 billion, more than double what the US payment company found useful in the last round of fundraising …
Read More »
[ad_1] Alexion Pharmaceuticals Inc. ALXN, + 0.37% Wednesday announced an agreement to purchase Syntimmune for a total value of $ 1.2 billion. Syntimmune is a clinical stage biotechnology company that is currently …
Read More »